Project
ALTITUDE
Completed ยท 2007 until 2011
Rickli Hans
Type
Range
Units
Status
Start Date
End Date
Financing
Study Design
Keywords
Brief description/objective
A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality.
ALTITUDE : ALiskiren Trial In Type 2 diabetes Using cardio-renal Disease Endpoints (CSPP100E2337)